QuickVue Influenza A + B Test Field Study

Completed

Conditions studied: Influenza A, Influenza B

In brief

Demonstrate improved clinical performance of visually read QuickVue Influenza A+B test.

Key facts

Study ID: NCT03417869
Run by: Quidel Corporation
People needed: 1381
Starts: 2017-02-16
Expected to finish: 2018-02-01
Last updated by the study team: 2018-03-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Subjects will be recruited from the general population as they present to the clinical facility. Subjects must have had a fever within the last two days and exhibiting one or more symptoms characteristic of influenza. They must meet the following criteria to be eligible for enrollment:
Male or Female of all ages (with appropriate consent).
The subject must have had of a fever, ≥ 37.8º C (100º F), within the last two days.
Must also be currently exhibiting one or more of the following symptoms characteristic of influenza-like-illness (ILI).
Nasal congestion
Rhinorrhea
Sore throat
Cough
Headache
Myalgia
Malaise

You may not qualify if…

1. Has undergone treatment with anti-influenza antivirals within the previous 7 days, to include but not be limited to, Amantadine, Rimantadine, Ribavirin, Oseltamivir, Zanamivir or any other antiviral currently available in these classes.
Has been vaccinated by means of an influenza nasal spray/mist vaccine within the previous 7 days.
Unable to understand and consent to participation; for minors this includes parent or legal guardian.

Where it is running

Alliance Urgent Care — Phoenix, Arizona, United States
Twelve Corners Pediatrics — Rochester, New York, United States
Veritas, P.A. — Belton, Texas, United States
City Doc Urgent Care — Dallas, Texas, United States
Advanced Pediatrics — Vienna, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.